Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Rosseneu, M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 96 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Demeester, N; Mertens, C; Caster, H; Goethals, M; Vandekerckhove, J; Rosseneu, M; Labeur, C
      Comparison of the aggregation properties, secondary structure and apoptotic effects of wild-type, Flemish and Dutch N-terminally truncated amyloid beta peptides

      EUROPEAN JOURNAL OF NEUROSCIENCE
    2. Drouet, B; Fifre, A; Pincon-Raymond, M; Vandekerckhove, J; Rosseneu, M; Gueant, JL; Chambaz, J; Pillot, T
      ApoE protects cortical neurones against neurotoxicity induced by the non-fibrillar C-terminal domain of the amyloid-beta peptide

      JOURNAL OF NEUROCHEMISTRY
    3. Peelman, F; Vanloo, B; Verschelde, JL; Labeur, C; Caster, H; Taveirne, J; Verhee, A; Duverger, N; Vandekerckhove, J; Tavernier, J; Rosseneu, M
      Effect of mutations of N- and C-terminal charged residues on the activity of LCAT

      JOURNAL OF LIPID RESEARCH
    4. Roosbeek, S; Vanloo, B; Duverger, N; Caster, H; Breyne, J; De Beun, I; Patel, H; Vandekerckhove, J; Shoulders, C; Rosseneu, M; Peelman, F
      Three arginine residues in apolipoprotein A-I are critical for activation of lecithin : cholesterol acyltransferase

      JOURNAL OF LIPID RESEARCH
    5. Desrumaux, C; Labeur, C; Verhee, A; Tavernier, J; Vandekerckhove, J; Rosseneu, M; Peelman, F
      A hydrophobic cluster at the surface of the human plasma phospholipid transfer protein is critical for activity on high density lipoproteins

      JOURNAL OF BIOLOGICAL CHEMISTRY
    6. Chambenoit, O; Hamon, Y; Marguet, D; Rigneault, H; Rosseneu, M; Chimini, G
      Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter

      JOURNAL OF BIOLOGICAL CHEMISTRY
    7. Christiaens, B; Vanloo, B; Gouyette, C; Van Vynckt, I; Caster, H; Taveirne, J; Verhee, A; Labeur, C; Peelman, F; Vandekerckhove, J; Tavernier, J; Rosseneu, M
      Headgroup specificity of lecithin cholesterol acyltransferase for monomeric and vesicular phospholipids

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
    8. Demeester, N; Baier, G; Enzinger, C; Goethals, M; Vandekerckhove, J; Rosseneu, M; Labeur, C
      Apoptosis induced in neuronal cells by C-terminal amyloid beta-fragments is correlated with their aggregation properties in phospholipid membranes

      MOLECULAR MEMBRANE BIOLOGY
    9. Peelman, F; Vandekerckhove, J; Rosseneu, M
      Structure and function of lecithin cholesterol acyl transferase: new insights from structural predictions and animal models

      CURRENT OPINION IN LIPIDOLOGY
    10. Demeester, N; Castro, G; Desrumaux, C; De Geitere, C; Fruchart, JC; Santens, P; Mulleners, E; Engelborghs, S; De Deyn, PP; Vandekerckhove, J; Rosseneu, M; Labeur, C
      Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin : cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease

      JOURNAL OF LIPID RESEARCH
    11. Vanloo, B; Peelman, F; Deschuymere, K; Taveirne, J; Verhee, A; Gouyette, C; Labeur, C; Vandekerckhove, J; Tavernier, J; Rosseneu, M
      Relationship between structure and biochemical phenotype of lecithin : cholesterol acyltransferase (LCAT) mutants causing fish-eye disease

      JOURNAL OF LIPID RESEARCH
    12. Liu, HQ; Labeur, C; Xu, CF; Ferrell, R; Lins, L; Brasseur, R; Rosseneu, M; Weiss, KM; Humphries, SE; Talmud, PJ
      Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr

      JOURNAL OF LIPID RESEARCH
    13. Read, J; Anderson, TA; Ritchie, PJ; Vanloo, B; Amey, J; Levitt, D; Rosseneu, M; Scott, J; Shoulders, CC
      A mechanism of membrane neutral lipid acquisition by the microsomal triglyceride transfer protein

      JOURNAL OF BIOLOGICAL CHEMISTRY
    14. Liu, HQ; Talmud, PJ; Lins, L; Brasseur, R; Olivecrona, G; Peelman, F; Vandekerckhove, J; Rosseneu, M; Labeur, C
      Characterization of recombinant wild type and site-directed mutations of apolipoprotein C-III: Lipid binding, displacement of ApoE, and inhibition oflipoprotein lipase

      BIOCHEMISTRY
    15. Decout, A; Labeur, C; Vanloo, B; Goethals, M; Vandekerckhove, J; Brasseur, R; Rosseneu, M
      Contribution of the hydrophobicity gradient to the secondary structure andactivity of fusogenic peptides

      MOLECULAR MEMBRANE BIOLOGY
    16. Peelman, F; Vanloo, B; Perez-Mendez, O; Decout, A; Verschelde, JL; Labeur, C; Vinaimont, N; Verhee, A; Duverger, N; Brasseur, R; Vandekerckhove, J; Tavernier, J; Rosseneu, M
      Characterization of functional residues in the interfacial recognition domain of lecithin cholesterol acyltransferase (LCAT)

      PROTEIN ENGINEERING
    17. Ritchie, PJ; Decout, A; Amey, J; Mann, CJ; Read, J; Rosseneu, M; Scott, J; Shoulders, CC
      Baculovirus expression and biochemical characterization of the human microsomal triglyceride transfer protein

      BIOCHEMICAL JOURNAL
    18. Pillot, T; Drouet, B; Queille, S; Labeur, C; Vandekerckhove, J; Rosseneu, M; Pincon-Raymond, M; Chambaz, J
      The nonfibrillar amyloid beta-peptide induces apoptotic neuronal cell death: Involvement of its C-terminal fusogenic domain

      JOURNAL OF NEUROCHEMISTRY
    19. Lins, L; Thomas-Soumarmon, A; Pillot, T; Vandekerckhove, J; Rosseneu, M; Brasseur, R
      Molecular determinants of the interaction between the C-terminal domain ofAlzheimer's beta-amyloid peptide and apolipoprotein E alpha-helices

      JOURNAL OF NEUROCHEMISTRY
    20. Pillot, T; Goethals, M; Najib, J; Labeur, C; Lins, L; Chambaz, J; Brasseur, R; Vandekerckhove, J; Rosseneu, M
      beta-amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: Relevance to Alzheimer's disease

      JOURNAL OF NEUROCHEMISTRY
    21. Mann, CJ; Anderson, TA; Read, J; Chester, SA; Harrison, GB; Kochl, S; Ritchie, PJ; Bradbury, P; Hussain, FS; Amey, J; Vanloo, B; Rosseneu, M; Infante, R; Hancock, JM; Levitt, DG; Banaszak, LJ; Scott, J; Shoulders, CC
      The structure of vitellogenin provides a molecular model for the assembly and secretion of atherogenic lipoproteins

      JOURNAL OF MOLECULAR BIOLOGY
    22. Peelman, F; Verschelde, JL; Vanloo, B; Ampe, C; Labeur, C; Tavernier, J; Vandekerckhove, J; Rosseneu, M
      Effects of natural mutations in lecithin : cholesterol acyltransferase on the enzyme structure and activity

      JOURNAL OF LIPID RESEARCH
    23. Rosseneu, M; Peelman, F; Verschelde, JL; Vanloo, B; Labeur, C; Tavernier, J; Vandekerckhove, J
      LCAT defects and low HDL levels

      ATHEROSCLEROSIS
    24. Dallongeville, J; Tiret, L; Visvikis, S; O'Reilly, DSJ; Saava, M; Tsitouris, G; Rosseneu, M; DeBacker, G; Humphries, SE; Beisiegel, U
      Effect of apo E phenotype on plasma postprandial triglyceride levels in young male adults with and without a familial history of myocardial infarction: the EARS II study

      ATHEROSCLEROSIS
    25. Brites, FD; Cavallero, E; de Geitere, C; Nicolaiew, N; Jacotot, B; Rosseneu, M; Fruchart, JC; Wikinski, RL; Castro, GR
      Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patients

      CLINICA CHIMICA ACTA
    26. Rosseneu, M; Labeur, C
      Immunological assays of plasma apolipoproteins

      LIPOPROTEINS IN HEALTH AND DISEASE
    27. PEELMAN F; VINAIMONT N; VERHEE A; VANLOO B; VERSCHELDE JL; LABEUR C; SEGURETMACE S; DUVERGER N; HUTCHINSON G; VANDEKERCKHOVE J; TAVERNIER J; ROSSENEU M
      A PROPOSED ARCHITECTURE FOR LECITHIN-CHOLESTEROL ACYL TRANSFERASE (LCAT) - IDENTIFICATION OF THE CATALYTIC TRIAD AND MOLECULAR MODELING

      Protein science
    28. SCHIELE F; BARBIER A; VISVIKIS A; AGGERBECK L; ROSSENEU M; HAVEKES L; HUTTINGER M; PROFILIS C; SIEST G
      FEASIBILITY OF A RECOMBINANT HUMAN APOLIPOPROTEIN-E REFERENCE MATERIAL

      Fresenius' journal of analytical chemistry
    29. MERO N; VANTOL A; SCHEEK LM; VANGENT T; LABEUR C; ROSSENEU M; TASKINEN MR
      DECREASED POSTPRANDIAL HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-E IN NORMOLIPIDEMIC SMOKING MEN - RELATIONS WITH LIPID TRANSFER PROTEINS AND LCAT ACTIVITIES

      Journal of lipid research
    30. LABEUR C; LAMBERT G; VANCAUTEREN T; DUVERGER N; VANLOO B; CHAMBAZ J; VANDEKERCKHOVE J; CASTRO G; ROSSENEU M
      DISPLACEMENT OF APO A-I FROM HDL BY APO A-II OR ITS C-TERMINAL HELIX PROMOTES THE FORMATION OF PRE-BETA(1) MIGRATING PARTICLES AND DECREASES LCAT ACTIVATION

      Atherosclerosis (Amsterdam)
    31. ROSSENEU M
      RELATIONSHIP BETWEEN STRUCTURE AND METABOLIC FUNCTION OF LCAT

      Atherosclerosis (Amsterdam)
    32. Nion, S; Demoor, L; Boutillon, C; Luchoomun, J; Vanloo, B; Fievet, C; Castro, G; Rosseneu, M; Fruchart, JC; Tartar, A; Clavey, V
      Branched synthetic peptide constructs mimic cellular binding and efflux ofapolipoprotein AI in reconstituted high density lipoproteins

      ATHEROSCLEROSIS
    33. MERO N; SYVANNE M; ROSSENEU M; LABEUR C; HILDEN H; TASKINEN MR
      COMPARISON OF 3 FATTY MEALS IN HEALTHY NORMOLIPIDEMIC MEN - HIGH POSTPRANDIAL RETINYL ESTER RESPONSE TO SOYBEAN OIL

      European journal of clinical investigation
    34. PEREZMENDEZ O; VANLOO B; DECOUT A; GOETHALS M; PEELMAN F; VANDEKERCKHOVE J; BRASSEUR R; ROSSENEU M
      CONTRIBUTION OF THE HYDROPHOBICITY GRADIENT OF AN AMPHIPATHIC PEPTIDETO ITS MODE OF ASSOCIATION WITH LIPIDS

      European journal of biochemistry
    35. LAMBERT G; DECOUT A; VANLOO B; ROUY D; DUVERGER N; KALOPISSIS A; VADEKERCKHOVE J; CHAMBAZ J; BRASSEUR R; ROSSENEU M
      THE C-TERMINAL HELIX OF HUMAN APOLIPOPROTEIN AII PROMOTES THE FUSION OF UNILAMELLAR LIPOSOMES AND DISPLACES APOLIPOPROTEIN AI FROM HIGH-DENSITY-LIPOPROTEINS

      European journal of biochemistry
    36. READ J; MANN C; VANLOO B; BRASSEUR R; ROSSENEU M; SCOTT J; SHOULDERS CC
      FUSOGENIC PEPTIDES MEDIATE TRIGLYCERIDE CAPTURE BY MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN

      Circulation
    37. Dobretsov, GE; Dergunov, AD; Taveirne, J; Caster, H; Vanloo, B; Rosseneu, M
      Apolipoprotein localization in reconstituted HDL particles: fluorescence energy transfer study

      CHEMISTRY AND PHYSICS OF LIPIDS
    38. DECOUT A; LABEUR C; GOETHALS M; BRASSEUR R; VANDEKERCKHOVE J; ROSSENEU M
      ENHANCED EFFICIENCY OF A TARGETED FUSOGENIC PEPTIDE

      Biochimica et biophysica acta. Biomembranes
    39. BOER JMA; EHNHOLM C; MENZEL HJ; HAVEKES LM; ROSSENEU M; OREILLY DS; TIRET L
      INTERACTIONS BETWEEN LIFE-STYLE-RELATED FACTORS AND THE APOE POLYMORPHISM ON PLASMA-LIPIDS AND APOLIPOPROTEINS - THE EARS STUDY

      Arteriosclerosis, thrombosis, and vascular biology
    40. LABEUR C; LINS L; VANLOO B; BAERT J; BRASSEUR R; ROSSENEU M
      DESIGN OF A NEW CLASS OF AMPHIPATHIC HELICAL PEPTIDES FOR THE PLASMA APOLIPOPROTEINS THAT PROMOTE CELLULAR CHOLESTEROL EFFLUX BUT DO NOT ACTIVATE LCAT

      Arteriosclerosis, thrombosis, and vascular biology
    41. BRASSEUR R; PILLOT T; LINS L; VANDEKERCKHOVE J; ROSSENEU M
      PEPTIDES IN MEMBRANES - TIPPING THE BALANCE OF MEMBRANE STABILITY

      Trends in biochemical sciences
    42. PILLOT T; BRASSEUR R; VANDEKERCKHOVE J; ROSSENEU M
      APOLIPOPROTEIN-E INHIBITS LIPOSOME FUSION INDUCED BY THE ALZHEIMERS BETA-AMYLOID PEPTIDE

      NMCD. Nutrition Metabolism and Cardiovascular Diseases
    43. PEACOCK RE; TEMPLE A; GUDNASON V; ROSSENEU M; HUMPHRIES SE
      VARIATION AT THE LIPOPROTEIN-LIPASE AND APOLIPOPROTEIN AI-CIII GENE LOCI ARE ASSOCIATED WITH FASTING LIPID AND LIPOPROTEIN TRAITS IN A POPULATION-SAMPLE FROM ICELAND - INTERACTION BETWEEN GENOTYPE, GENDER, ANDSMOKING STATUS

      Genetic epidemiology
    44. PILLOT T; LINS L; GOETHALS M; VANLOO B; BAERT J; VANDEKERCKHOVE J; ROSSENEU M; BRASSEUR R
      THE 118-135 PEPTIDE LOT THE HUMAN PRION PROTEIN FORMS AMYLOID FIBRILSAND INDUCES LIPOSOME FUSION

      Journal of Molecular Biology
    45. SYVANNE M; TALMUD PJ; HUMPHRIES SE; FISHER RM; ROSSENEU M; HILDEN H; TASKINEN MR
      DETERMINANTS OF POSTPRANDIAL LIPEMIA IN MEN WITH CORONARY-ARTERY DISEASE AND LOW-LEVELS OF HDL CHOLESTEROL

      Journal of lipid research
    46. LAMBERT G; VANCAUTEREN T; KALOPISSIS A; CHAMBAZ J; ROSSENEU M
      DISPLACEMENT OF APO A-I BY APO A-II RESULTS IN A DECREASE OF THE LCATACTIVITY AND PROMOTES THE FORMATION OF PRE-BETA HDL

      Atherosclerosis
    47. VANLOO B; PEREZMENDEZ O; LAMBERT G; BRASSEUR R; ROSSENEU M
      CONTRIBUTION APO A-II AND LCAT OBLIQUE PEPTIDES TO HDL METABOLISM

      Atherosclerosis
    48. PEELMAN F; VANLOO B; BRASSEUR R; VANDERKERCKHOVE J; ROSSENEU M
      LIPID-BINDING PROPERTIES OF AN AMPHIPATHIC HELICAL SEGMENT OF LECITHIN-CHOLESTEROL ACYL TRANSFERASE

      Atherosclerosis
    49. LABEUR C; BRASSEUR R; ROSSENEU M
      DESIGN OF A NEW CLASS OF AMPHIPATHIC HELICAL PEPTIDES FOR THE PLASMA APOLIPOPROTEINS WHICH PROMOTE CELLULAR CHOLESTEROL EFFLUX BUT DO NOT ACTIVATE LCAT

      Atherosclerosis
    50. PILLOT T; LINS L; NAJIB J; BRASSEUR R; ROSSENEU M
      INTERACTION OF HUMAN APOE WITH THE FUSOGENIC C-TERMINAL ALZHEIMERS BETA-AMYLOID PEPTIDE IS MEDIATED BY THE LIPID-BINDING DOMAIN OF APOE

      Atherosclerosis
    51. ROSSENEU M; LAMBERT G; VANLOO B; BRASSEUR R; BANDEKERCKHOVE J
      CONTRIBUTION OF THE C-TERMINAL HELIX OF APO A-II TO THE DISPLACEMENT OF APO A-I FROM HDL

      Atherosclerosis
    52. PEELMAN F; GOETHALS M; VANLOO B; LABEUR C; BRASSEUR R; VANDEKERCKHOVE J; ROSSENEU M
      STRUCTURAL AND FUNCTIONAL-PROPERTIES OF THE 154-171-WILD-TYPE AND VARIANT PEPTIDES OF HUMAN LECITHIN-CHOLESTEROL ACYLTRANSFERASE

      European journal of biochemistry
    53. PILLOT T; GOETHALS M; VANLOO B; LINS L; BRASSEUR R; VANDEKERCKHOVE J; ROSSENEU M
      SPECIFIC MODULATION OF THE FUSOGENIC PROPERTIES OF THE ALZHEIMER BETA-AMYLOID PEPTIDE BY APOLIPOPROTEIN-E ISOFORMS

      European journal of biochemistry
    54. SANG GW; YANG H; ZHANG MY; JIANG HY; LU FY; EZCURRA E; SANTANA F; MONTEAGUDO G; PEREIRA G; AFFANDI B; SUHERMAN SK; YANG PJ; SONG S; CHEN JK; SHAO JY; DONG JH; ROSSENEU M; ALI M; DARCANGUES C; HEADY A; NOONAN L; OLAYINKA I; PIAGGIO G
      COMPARATIVE-STUDY OF THE EFFECTS OF 2 ONCE-A-MONTH INJECTABLE STEROIDAL CONTRACEPTIVES (MESIGYNA(R) AND CYCLOFEM(R)) ON LIPID AND LIPOPROTEIN METABOLISM

      Contraception
    55. DEPAUW M; VANLOO B; DERGUNOV AD; DEVREESE AM; BAERT J; BRASSEUR R; ROSSENEU M
      COMPOSITION AND STRUCTURAL AND FUNCTIONAL-PROPERTIES OF DISCOIDAL ANDSPHERICAL PHOSPHOLIPID-APOE3 COMPLEXES

      Biochemistry
    56. DERGUNOV AD; TAVEIRNE J; VANLOO B; CASTER H; ROSSENEU M
      STRUCTURAL ORGANIZATION OF LIPID PHASE AND PROTEIN-LIPID INTERFACE INAPOLIPOPROTEIN-PHOSPHOLIPID RECOMBINANTS - INFLUENCE OF CHOLESTEROL

      Biochimica et biophysica acta, L. Lipids and lipid metabolism
    57. PILLOT T; BARBIER A; VISVIKIS A; LOZACH K; ROSSENEU M; VANDEKERCKHOVE J; SIEST G
      SINGLE-STEP PURIFICATION OF 2 FUNCTIONAL HUMAN APOLIPOPROTEIN-E VARIANTS HYPEREXPRESSED IN ESCHERICHIA-COLI

      Protein expression and purification
    58. BRAECKMAN L; DEBACQUER D; ROSSENEU M; DEBACKER G
      DETERMINANTS OF LIPOPROTEIN(A) LEVELS IN A MIDDLE-AGED WORKING POPULATION

      European heart journal
    59. PILLOT T; GOETHALS M; VANLOO B; TALUSSOT C; BRASSEUR R; VANDEKERCKHOVE J; ROSSENEU M; LINS L
      FUSOGENIC PROPERTIES OF THE C-TERMINAL DOMAIN OF THE ALZHEIMER BETA-AMYLOID PEPTIDE

      The Journal of biological chemistry
    60. BRAECKMAN L; DEBACQUER D; ROSSENEU M; DEBACKER G
      APOLIPOPROTEIN-E POLYMORPHISM IN MIDDLE-AGED BELGIAN MEN - PHENOTYPE DISTRIBUTION AND RELATION TO SERUM-LIPIDS AND LIPOPROTEINS

      Atherosclerosis
    61. MATTHYS KE; VANHOVE CE; JORENS PG; ROSSENEU M; MARESCAU B; HERMAN AG; BULT H
      DUAL EFFECTS OF OXIDIZED LOW-DENSITY-LIPOPROTEIN ON IMMUNE-STIMULATEDNITRIC-OXIDE AND PROSTAGLANDIN RELEASE IN MACROPHAGES

      European journal of pharmacology
    62. BENETOLLO C; LAMBERT G; TALUSSOT C; VANLOO B; VANCAUTEREN T; ROUY D; DUBOIS H; BAERT J; KALOPISSIS A; DENEFLE P; CHAMBAZ J; BRASSEUR R; ROSSENEU M
      LIPID-BINDING PROPERTIES OF SYNTHETIC PEPTIDE-FRAGMENTS OF HUMAN APOLIPOPROTEIN A-II

      European journal of biochemistry
    63. DEMOOR L; BOUTILLON C; FIEVET C; VANLOO B; BAERT J; ROSSENEU M; FRUCHART JC; TARTAR A
      BRANCHED SYNTHETIC CONSTRUCTS THAT MIMIC THE PHYSICOCHEMICAL PROPERTIES OF APOLIPOPROTEIN-AI IN RECONSTITUTED HIGH-DENSITY-LIPOPROTEINS

      European journal of biochemistry
    64. LAMBERT G; VANCAUTEREN T; ROUY D; DENEFFE P; KALOPISSIS A; CHAMBAZ J; ROSSENEU M
      MECHANISM OF THE DISPLACEMENT OF APO A-I BY APO A-II IN NATIVE AND INR-HDL - CONTRIBUTION OF THE C-TERMINAL HELIX OF APO A-II

      Circulation
    65. PILLOT T; LINS L; VANLOO B; BRASSEUR R; VANDEKERCKHOVE J; ROSSENEU M
      THE C-TERMINAL DOMAIN OF THE ALZHEIMER BETA-AMYLOID PROTEIN IS A FUSION PEPTIDE - ISOFORM-SPECIFIC MODULATION OF THE FUSOGENIC PROPERTIES BY HUMAN APOLIPOPROTEIN-E

      Circulation
    66. KLAUSEN IC; BEISIEGEL U; MENZEL HJ; ROSSENEU M; NICAUD V; FAERGEMAN O
      APO(A) PHENOTYPES AND LP(A) CONCENTRATIONS IN OFFSPRING OF MEN WITH AND WITHOUT MYOCARDIAL-INFARCTION - THE EARS STUDY

      Arteriosclerosis, thrombosis, and vascular biology
    67. ROSSENEU M; LABEUR C
      PHYSIOLOGICAL SIGNIFICANCE OF APOLIPOPROTEIN MUTANTS

      The FASEB journal
    68. DEBOEVER E; DEBACQUER D; BRAECKMAN L; BAELE G; ROSSENEU M; DEBACKER G
      RELATION OF FIBRINOGEN TO LIFE-STYLES AND TO CARDIOVASCULAR RISK-FACTORS IN A WORKING POPULATION

      International journal of epidemiology
    69. SANCHEZPOZO A; RAMIREZ M; GIL A; MALDONADO J; VANBIERVLIET JP; ROSSENEU M
      DIETARY NUCLEOTIDES ENHANCE PLASMA LECITHIN-CHOLESTEROL ACYL TRANSFERASE-ACTIVITY AND APOLIPOPROTEIN A-IV CONCENTRATION IN PRETERM NEWBORN-INFANTS

      Pediatric research
    70. VANLOO B; DEMOOR L; BOUTILLON C; LINS L; BRASSEUR R; BAERT J; FRUCHART JC; TARTAR A; ROSSENEU M
      ASSOCIATION OF SYNTHETIC PEPTIDE-FRAGMENTS OF HUMAN APOLIPOPROTEIN-A-I WITH PHOSPHOLIPIDS

      Journal of lipid research
    71. MATTHYS KE; VANHOVE CE; JORENS PG; MARESCAU B; ROSSENEU M; HERMAN AG; BULT H
      OXIDIZED LOW-DENSITY-LIPOPROTEIN AFFECTS PROSTAGLANDIN PRODUCTION ANDNITRIC-OXIDE SYNTHASE ACTIVITY IN MACROPHAGES

      British Journal of Pharmacology
    72. HOLVOET P; ZHAO ZA; VANLOO B; VOS R; DERIDDER E; DHOEST A; TAVEIRNE J; BROUWERS E; DEMARSIN E; ENGELBORGHS Y; ROSSENEU M; COLLEN D; BRASSEUR R
      PHOSPHOLIPID-BINDING AND LECITHIN-CHOLESTEROL ACYLTRANSFERASE ACTIVATION PROPERTIES OF APOLIPOPROTEIN-A-I MUTANTS

      Biochemistry
    73. DEPAUW M; VANLOO B; WEISGRABER K; ROSSENEU M
      COMPARISON OF LIPID-BINDING AND LECITHIN-CHOLESTEROL ACYLTRANSFERASE ACTIVATION OF THE AMINO-TERMINAL AND CARBOXYL-TERMINAL DOMAINS OF HUMAN APOLIPOPROTEIN E3

      Biochemistry
    74. LINS L; BRASSEUR R; DEPAUW M; VANBIERVLIET JP; RUYSSCHAERT JM; ROSSENEU M; VANLOO B
      HELIX HELIX INTERACTIONS IN RECONSTITUTED HIGH-DENSITY-LIPOPROTEINS

      Biochimica et biophysica acta, L. Lipids and lipid metabolism
    75. MATTHYS KE; JORENS PG; MARESCAU B; ROSSENEU M; BULT H; HERMAN AG
      OXIDIZED LIPOPROTEINS SUPPRESS NITRIC-OXIDE SYNTHASE IN MACROPHAGES -STUDY OF GLUCOCORTICOID RECEPTOR INVOLVEMENT

      Mediators of inflammation
    76. KOHN G; SAWATZKI G; VANBIERVLIET JP; ROSSENEU M
      DIET AND THE ESSENTIAL FATTY-ACID STATUS OF TERM INFANTS

      Acta paediatrica
    77. LINS L; BRASSEUR R; ROSSENEU M; YANG CY; SPARROW DA; SPARROW JT; GOTTO AM; RUYSSCHAERT JM
      STRUCTURE AND ORIENTATION OF APO-B-100 PEPTIDES INTO A LIPID BILAYER

      Journal of protein chemistry
    78. DERGUNOV AD; ROSSENEU M
      THE SIGNIFICANCE OF APOLIPOPROTEIN-E STRUCTURE TO THE METABOLISM OF PLASMA TRIGLYCERIDE-RICH LIPOPROTEINS

      Biological chemistry Hoppe-Seyler
    79. DERGUNOV AD; VOROTNIKOVA YY; DEPAUW M; ROSSENEU M
      APOLIPOPROTEIN-E SELF-ASSOCIATION IN SOLUTION STUDIED BY NONRADIATIVEENERGY-TRANSFER

      Journal of biochemical and biophysical methods
    80. HOLVOET P; PEREZ G; BERNAR H; BROUWERS E; VANLOO B; ROSSENEU M; COLLEN D
      STIMULATION WITH A MONOCLONAL-ANTIBODY (MAB4E4) OF SCAVENGER RECEPTOR-MEDIATED UPTAKE OF CHEMICALLY-MODIFIED LOW-DENSITY LIPOPROTEINS BY THP-1-DERIVED MACROPHAGES ENHANCES FOAM CELL GENERATION

      The Journal of clinical investigation
    81. EMMANUEL F; STEINMETZ A; ROSSENEU M; BRASSEUR R; GOSSELET N; ATTENOT F; CUINE S; SEGURET S; LATTA M; FRUCHART JC; DENEFLE P
      IDENTIFICATION OF SPECIFIC AMPHIPATHIC ALPHA-HELICAL SEQUENCE OF HUMAN APOLIPOPROTEIN A-IV INVOLVED IN LECITHIN-CHOLESTEROL ACYLTRANSFERASEACTIVATION

      The Journal of biological chemistry
    82. ROSSENEU M; CAMBIEN F; VINAIMONT N; NICAUD V; DEBACKER G
      BIOMARKERS OF DIETARY-FAT COMPOSITION IN YOUNG-ADULTS WITH A PARENTALHISTORY OF PREMATURE CORONARY HEART-DISEASE COMPARED WITH CONTROLS - THE EARS STUDY

      Atherosclerosis
    83. EHNHOLM C; TENKANEN H; DEKNIJFF P; HAVEKES L; ROSSENEU M; MENZEL HJ; TIRET L
      GENETIC-POLYMORPHISM OF APOLIPOPROTEIN-A-IV IN 5 DIFFERENT REGIONS OFEUROPE - RELATIONS TO PLASMA-LIPOPROTEINS AND TO HISTORY OF MYOCARDIAL-INFARCTION - THE EARS STUDY

      Atherosclerosis
    84. SYVANNE M; ROSSENEU M; LABEUR C; HILDEN H; TASKINEN MR
      ENRICHMENT WITH APOLIPOPROTEIN-E CHARACTERIZES POSTPRANDIAL TG-RICH LIPOPROTEINS IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS AND CORONARY-ARTERY DISEASE - A PRELIMINARY-REPORT

      Atherosclerosis
    85. LOPEZ J; LATTA M; COLLET X; VANLOO B; JUNG G; DENEFLE P; ROSSENEU M; CHAMBAZ J
      PURIFICATION AND CHARACTERIZATION OF RECOMBINANT HUMAN APOLIPOPROTEINA-II EXPRESSED IN ESCHERICHIA-COLI

      European journal of biochemistry
    86. ROSSENEU M; FRUCHART JC; BARD JM; NICAUD V; VINAIMONT N; CAMBIEN F; DEBACKER G
      PLASMA APOLIPOPROTEIN CONCENTRATIONS IN YOUNG-ADULTS WITH A PARENTAL HISTORY OF PREMATURE CORONARY HEART-DISEASE AND IN CONTROL SUBJECTS - THE EARS STUDY

      Circulation
    87. LABEUR C; ROSSENEU M; HENDERSON O
      INTERNATIONAL LP(A) STANDARDIZATION

      Chemistry and physics of lipids
    88. LUCHOOMUN J; THERET N; CLAVEY V; DUCHATEAU P; ROSSENEU M; BRASSEUR R; DENEFLE P; FRUCHART JC; CASTRO GR
      STRUCTURAL DOMAIN OF APOLIPOPROTEIN-A-I INVOLVED IN ITS INTERACTION WITH CELLS

      Biochimica et biophysica acta, L. Lipids and lipid metabolism
    89. ANTIKAINEN M; HOLMBERG C; OLIVECRONA T; BENGTSSONOLIVECRONA G; LABEUR C; ROSSENEU M; TASKINEN MR
      CHANGES IN BIOLOGICAL-ACTIVITY AND IMMUNOREACTIVE MASS OF LIPOPROTEIN-LIPASE IN CONGENITAL NEPHROSIS - RELATIONSHIP TO HYPERTRIGLYCERIDEMIA

      European journal of clinical investigation
    90. LUCHOOMUN J; DEMOOR L; TARTAR A; ROSSENEU M; DENEFLE P; CASTRO G; FRUCHART JC
      A SYNTHETIC TETRAMERIC PEPTIDE THAT MIMICS PROPERTIES OF APO-AI

      Circulation
    91. BRASSEUR R; VANLOO B; DELEYS R; LINS L; LABEUR C; TAVEIRNE J; RUYSSCHAERT JM; ROSSENEU M
      SYNTHETIC MODEL PEPTIDES FOR APOLIPOPROTEINS .1. DESIGN AND PROPERTIES OF SYNTHETIC MODEL PEPTIDES FOR THE AMPHIPATHIC HELICES OF THE PLASMA APOLIPOPROTEINS

      Biochimica et biophysica acta
    92. CORIJN J; DELEYS R; LABEUR C; VANLOO B; LINS L; BRASSEUR R; BAERT J; RUYSSCHAERT JM; ROSSENEU M
      SYNTHETIC MODEL PEPTIDES FOR APOLIPOPROTEINS .2. CHARACTERIZATION OF THE DISCOIDAL COMPLEXES GENERATED BETWEEN PHOSPHOLIPIDS AND SYNTHETIC MODEL PEPTIDES FOR APOLIPOPROTEINS

      Biochimica et biophysica acta
    93. LINS L; PIRON S; CONRATH K; VANLOO B; BRASSEUR R; ROSSENEU M; BAERT J; RUYSSCHAERT JM
      ENZYMATIC-HYDROLYSIS OF RECONSTITUTED DIMYRISTOYLPHOSPHATIDYLCHOLINE APO A-I COMPLEXES

      Biochimica et biophysica acta
    94. LINS L; BRASSEUR R; ROSSENEU M; VANLOO B; RUYSSCHAERT JM
      STRUCTURE OF THE APOLIPOPROTEIN A-IV LIPID DISCOIDAL COMPLEXES - AN ATTENUATED TOTAL-REFLECTION POLARIZED FOURIER-TRANSFORM INFRARED-SPECTROSCOPY STUDY/

      Biochimica et biophysica acta
    95. GOORMAGHTIGH E; CABIAUX V; DEMEUTTER J; ROSSENEU M; RUYSSCHAERT JM
      SECONDARY STRUCTURE OF THE PARTICLE ASSOCIATING DOMAIN OF APOLIPOPROTEIN-B-100 IN LOW-DENSITY-LIPOPROTEIN BY ATTENUATED TOTAL-REFLECTION INFRARED-SPECTROSCOPY

      Biochemistry
    96. ROSSENEU M; LABEUR C
      METHODOLOGICAL ASPECTS OF APOLIPOPROTEIN QUANTITATION

      Annales de biologie clinique


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 10:44:43